BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 3153438)

  • 21. Phosphatidylserine enhances the ability of epidermal Langerhans cells to induce contact hypersensitivity.
    Girolomoni G; Pastore S; Zacchi V; Cavani A; Marconi A; Giannetti A
    J Immunol; 1993 May; 150(10):4236-43. PubMed ID: 8482834
    [TBL] [Abstract][Full Text] [Related]  

  • 22. T and B lymphocytes, macrophages and Langerhans' cells during the course of contact allergic and irritant skin reactions in man.
    Ranki A; Kanerva L; Förström L; Konttinen Y; Mustakallio KK
    Acta Derm Venereol; 1983; 63(5):376-83. PubMed ID: 6197834
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The immune functions of epidermal cells.
    Stingl G; Tschachler E; Groh V; Wolff K; Hauser C
    Immunol Ser; 1989; 46():3-72. PubMed ID: 2488861
    [No Abstract]   [Full Text] [Related]  

  • 24. Use of monoclonal antibodies specific for T cell subsets in cutaneous disorders: I. Quantitative analysis of peripheral blood lymphocytes.
    Faure M; Thivolet J
    J Clin Immunol; 1982 Jul; 2(3 Suppl):103S-110S. PubMed ID: 6215423
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Langerhans cells but not monocytes are capable of antigen presentation in vitro in corticosteroid contact hypersensitivity.
    Lauerma AI; Räsänen L; Reunala T; Reitamo S
    Br J Dermatol; 1990 Dec; 123(6):699-705. PubMed ID: 2265088
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunohistochemical studies using monoclonal antibodies on lymph nodes from patients with mycosis fungoides and Sézary's syndrome.
    Willemze R; Scheffer E; Meijer CJ
    Am J Pathol; 1985 Jul; 120(1):46-54. PubMed ID: 3893151
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cyclosporine A inhibits accessory cell and antigen-presenting cell functions of epidermal Langerhans cells.
    Furue M; Katz SI
    Transplant Proc; 1988 Apr; 20(2 Suppl 2):87-91. PubMed ID: 3259044
    [No Abstract]   [Full Text] [Related]  

  • 28. Freshly isolated Langerhans cells negatively regulate naïve T cell activation in response to peptide antigen through cell-to-cell contact.
    Imai Y; Hayashi N; Yasuda K; Tsutsui H; Mizutani H; Nakanishi K
    J Dermatol Sci; 2008 Jul; 51(1):19-29. PubMed ID: 18367382
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The use of a double-label immunoperoxidase monoclonal antibody technique in the investigation of patients with mycosis fungoides.
    Mackie RM; Turbitt ML
    Br J Dermatol; 1982 Apr; 106(4):379-84. PubMed ID: 6462162
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of dermal cells from normal and ultraviolet B-damaged skin in induction of contact hypersensitivity and tolerance.
    Kurimoto I; Arana M; Streilein JW
    J Immunol; 1994 Apr; 152(7):3317-23. PubMed ID: 8144917
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Demonstration of OKT 6-reactive cells in mycosis fungoides.
    McMillan EM; Beeman K; Wasik R; Everett MA
    J Am Acad Dermatol; 1982 May; 6(5):880-7. PubMed ID: 7047585
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Langerhans' cells: a distinctive member of bone marrow-derived dendritic cells.
    Stingl G; Romani N; Wolff K
    Adv Dermatol; 1987; 2():269-81. PubMed ID: 3079258
    [No Abstract]   [Full Text] [Related]  

  • 33. Accelerated dendritic-cell migration and T-cell priming in SPARC-deficient mice.
    Sangaletti S; Gioiosa L; Guiducci C; Rotta G; Rescigno M; Stoppacciaro A; Chiodoni C; Colombo MP
    J Cell Sci; 2005 Aug; 118(Pt 16):3685-94. PubMed ID: 16046482
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cell-mediated immunity in cutaneous disease.
    Breathnach SM; Katz SI
    Hum Pathol; 1986 Feb; 17(2):161-7. PubMed ID: 2936669
    [No Abstract]   [Full Text] [Related]  

  • 35. The simultaneous presence of Langerhans' cell and interdigitating cell antigenic markers on inflammatory dendritic cells.
    Alegre VA; MacDonald DM; Poulter LW
    Clin Exp Immunol; 1986 May; 64(2):330-3. PubMed ID: 3527504
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Functional CD86 (B7-2/B70) is predominantly expressed on Langerhans cells in atopic dermatitis.
    Ohki O; Yokozeki H; Katayama I; Umeda T; Azuma M; Okumura K; Nishioka K
    Br J Dermatol; 1997 Jun; 136(6):838-45. PubMed ID: 9217814
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro primary sensitization and restimulation of hapten-specific T cells by fresh and cultured human epidermal Langerhans' cells.
    Moulon C; Péguet-Navarro J; Courtellemont P; Redziniak G; Schmitt D
    Immunology; 1993 Nov; 80(3):373-9. PubMed ID: 7507088
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Immunological mechanisms of contact hypersensitivity].
    Silvennoinen-Kassinen S; Tiilikainen A
    Duodecim; 1985; 101(11):1056-62. PubMed ID: 3874763
    [No Abstract]   [Full Text] [Related]  

  • 39. In vivo treatment with anti-I-A antibodies: differential effects on Ia antigens and antigen-presenting cell function of spleen cells and epidermal Langerhans cells.
    Aberer W; Kruisbeek AM; Shimada S; Katz SI
    J Immunol; 1986 Feb; 136(3):830-6. PubMed ID: 3455705
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CD7 expression in reactive and malignant human skin T-lymphocytes.
    Alaibac M; Pigozzi B; Belloni-Fortina A; Michelotto A; Saponeri A; Peserico A
    Anticancer Res; 2003; 23(3B):2707-10. PubMed ID: 12894562
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.